Abstract
Background: Allergic Rhinitis is a common disorder, reports for at least 2.5% of all physicians’ visits, at the minimum of 2.1 million lost schools per year, roughly 6 million lost working days and 28 million restricted working days a year. Allergic rhinitis if left untreated can affect the upper and lower airways which in turn may alter the pulmonary functions .which readily can be investigated by performing Pulmonary Function Tests. (5. This study aims to understand the impaired spirometric changes in patients with Allergic Rhinitis and the efficacy of Topical Nasal Steroids on the treatment of Allergic Rhinitis in terms of improvement in Pulmonary Function Test parameters.
Methods: The study was conducted between February 2020 to December 2020 on 60 patients attending ENT OPD in Vinayaka Missions Kirupanandha Variyar Medical College and Hospital, Salem. All patients with Allergic Rhinitis fulfilling inclusion and exclusion criteria were seen at the otorhinolaryngology OPD and underwent a complete otorhinolaryngological examination, AEC and Spirometry.. Patients were then treated with topical nasal steroids for a period of 3 months. At the end of 3 months, patients were assessed and subjected to AEC and PFT. Pulmonary function parameters are compared before and after treatment with topical nasal steroids.
Results: 60 Patients; 28 male and 32 female were investigated with AEC and PFT before and After treatment with nasal Steroids. AEC values declined significantly after Treatment. FVC, FEV1 and FEV1/FVC ratio and MVV all Significantly improved after treatment.
Conclusions: Early identification of allergic rhinitis patient and efficient treatment prevents further progression of disease and its related morbidity. By using a simple, non-invasive spirometry we can identify obstruction of the smaller and the larger airways at an earlier stage in patients with allergic rhinitis. Thus proper and meticilous administration of intranasal steroids is highly recommended for the treatment of allergic rhinitis.
Keywords:
:Allergic Rhinitis, Topical Nasal Steroids, Spirometry
References
1. Wardlow, RS, Chrishanthan, N, et al. Preliminary criteria for the definition of allergic rhinitis: A systemic evaluation of clinical parameters in a disease cohort (I). Clin Exp Allergy 2000; 30:1314.
2. Settipane, RA. Demographics and epidemiology of allergic and nonallergic rhinitis. Allergy Asthma Proc 2001; 22:185.
3. S.N. Gaur, K. Gupta, S. Rajpal, A.B. Singh, A. Rohatgi. Prevalence of bronchial asthma and allergic rhinitis among urban and rural adult population of Delhi. Indian J Allergy Asthma Immunol 2006; 20(2) : 90 – 97.
4. Bachert C, EL-Akkad T. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis. Ann Allergy Asthma Immunol 2002; 89(3): 292-7.
5. Crapo, RO. Pulmonary function testing. N Engl J Med 1994; 331:25.
6. Pellegrino, R, Viegi, G, Brusasco, V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948.
7. Ferguson, GT, Enright, PL, Buist, AS, Higgins, MW. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest 2000; 117:1146.
8. Holm AF, Godthelp T, Fokkens WJ, Severijenen EA, Mulder PG, Vroom TM at al. LOmg term effects of corticosteroid nasal spray on nasal inflammatory cells in patients with perennial allergic rhinitis. Clin Exp Allergy 1999; 29(10): 1356-66.
9. Holm A, Dijkstra M, Kleinjan A, Severijan L, Boks S, Mulder P et al. Fluticasone propionate aqueous nasal spray redcues inflammatory cells in 100 unchallenged allergic nasal mucosa: effects of single allergen challenge. JAllergy clin Immunol 2001; 107: 627-33.
10. Dykewicz, MS, Fineman, S, Skoner, DP, et al. Diagnosis and management of rhinitis: Complete guidelines of the Joint Task Force on Practice Paramaters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998; 81:478.
11. Mandl M, Nolop K, Lutsky BN. Comparison of once daily momentasone furoate ( Nasonex) and Fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. Ann Allergy Asthma Immunol 1997;79(4) : 370-8.
12. Berlin JM, Golden SJ, Teets S, Lehmen EB, Lucas T, Craig TJ. Efficacy of asteroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. J. Am osteopath Assoc 2000; 100 (7 suppl) : S8-13.
13. Golden SJ, Teets S, Lehmen EB, Lucas T, Craig TJ. Efficacy of asteroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. J. Am osteopath Assoc 2000; 100 (7 suppl) : S8-13.
14. Charles Frank Schuler IV, Jenny Maribel Montejo, Allergic Rhinitis in Children and Adolescents. Pediatric clinics.2019 ;( 66): 981-993.
15. Robinson,Michael S. Blaiss,Eva Hammerby,Susan,Tessa Kennedy-Martin,Sarah Buchs. The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents A literature review Annals of Allergy, Asthma & Immunology 2018; (53) : 1023-1031.
16. Bunnag C, Jareoncharsri P, Tantilipikorn P, Vichyanond P, Pawankar R. Epidemiology and current status of allergic rhinitis and asthma in Thailand -- ARIA Asia-Pacific Workshop report. Asian Pac J Allergy Immunol. 2009 Mar;27(1):79-86.
17. Shreepad, S & Shetty, & Rai, Sheetal & Somayaji, Gangadhar & Zameel, Ali. (2014). Nasal Smear Eosinophil CountVs AEC of Patients diagnosed with Allergic Rhinitis Attending a Tertiary Care Hospital &the Effect of Treatment with a TopicalSteroid Nasal Spray on theSame. IOSR Journal of dental and medical sciences. 13. 2279-0853.
18. William F Ganong, Review of Medical Physiology, 23th edition, Lange publications 2008.
19. Giorgio C, Ignazio C, Maria AT, Andrea V. Bronchial hyperactivity and spirometric impairment in patients with perennial allergic rhinitis. Int Arch Allergy Immunol 2004;133:14-8
20. Gian LM, Ignazio C, Andrea V, Catherine K, Maria AT, Mario LR, et al. Role of forced expiratory flow at 25–75% as an early marker of small airways impairment in subjects with allergic rhinitis. Allergy Asthma Proc 28:74 –78, 2007.
21. Kessel A. The impact of intranasal corticosteroids on lung function in children with allergic rhinitis. Pediatr Pulmonol. 2014 Sep;49(9):932-7.
22. Lohia S, Schlosser RJ, Soler ZM. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy. 2013;68(5):569-79.
23. Ji XQ, Zhang NK, Shao MJ, Liu TT, Li SL. [Effects of nasal steroids on pulmonary function in patients with allergic rhinitis]. Lin Chuang er bi yan hou tou Jing wai ke za zhi = Journal of Clinical Otorhinolaryngology, Head, and Neck Surgery. 2016 Aug;30(15):1236-1239.
24. Riikka Leskelä, Minna Ruokonen, Matti Korppi, Heidi Kainulainen and Marita Paassilta. Association between allergic rhinitis and lung function in school children with asthma. Curr Pediatr Res 2013; 17 (1): 21-26.
25. Bochlecke BA, Merchant JA. The use of pulmonary function testing and questionnaire as epidemiologic tools in study of lung diseases
